BioSpace News Archive

Mainz Biomed N.V. announced that Bill Caragol, Chief Financial Officer, will present at the H.C. Wainwright Annual Global Investment Conference taking place from September 12-14, 2022.

Helsinn Group and Juniper Biologics Pte Ltd announced the signing of an exclusive distribution license and supply agreement to register, distribute, promote, market and sell LEDAGA® in Australia, Asia and the Middle East* as a topical treatment of mycosis fungoides-type cutaneous T-cell lymphoma in adults.

MannKind Corporation announced that its Chief Executive Officer, Michael Castagna, PharmD, will participate in a Fireside Chat at the H.C. Wainwright 24th Annual Global Investment Conference on Tuesday, September 13, 2022 at 12:00 PM ET at the Lotte New York Palace Hotel.

Brainomix, the AI-powered medtech solutions company, today announces that it has been awarded the national tender in Hungary to deploy its AI stroke imaging software across all stroke centers in Hungary as part of the National Institute for Health Development initiative to improve stroke care.

Hyloris Pharmaceuticals SA, a specialty biopharma company committed to addressing unmet medical needs through reinventing existing medications, reported its condensed consolidated financial results for the six-month period ending 30 June 2022, along with a year-to-date business update and an outlook.

Orexo AB, announces that the European Patent Office has granted the first European patent specifically relating to OX640, Orexo’s nasal adrenaline rescue medication based on the amorphOX® drug delivery platform.

Avacta Group plc announces that the first-in-human Phase I trial of AVA6000 Pro-doxorubicin will advance to the fourth dose cohort of patients following a positive review of the safety and tolerability data from the dosing of the third cohort.

Caris Life Sciences®, the leading molecular science and technology company actively developing and delivering innovative solutions to revolutionize health care, announced that The Medical College of Wisconsin Cancer Center has joined Caris’ Precision Oncology Alliance™.

Nuvalent, Inc. announced that James Porter, Ph.D., Chief Executive Officer, will participate in a fireside chat at the Wells Fargo 2022 Healthcare Conference on Thursday, September 8, 2022, at 2:35 p.m. ET in Boston.

Brazil is the first Latin American country to now welcome Tru Niagen®, with a strategy focused on reaching both consumers and Health Care Practitioners ChromaDex Corp. announced a partnership with MyPharma2Go to conduct cross-border sales of Tru Niagen® and Tru Niagen® PRO in Brazil, the first Latin American country to welcome the brand.